Alexion Pharma (Switzerland)

Alexion Pharma (Switzerland)

Alexion Pharmaceuticals, Inc., a subsidiary of AstraZeneca, is a pharmaceutical company headquartered in Boston, Massachusetts, specializing in orphan drugs for rare diseases. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Alexion Pharma (Switzerland), Switzerland, covering academic research published from 2000 to 2025. Read More.


Open Access Percentage

53%


Total
Publications

1.5K


Total Open
Publications

808


Total
Citations

21K


Open Access
Percentage

53%


Total
Publications

1.5K


Total Open
Publications

808


Total
Citations

21K

Wikipedia

Website

download

Breakdown

20% 27% 5% 48%

Publisher Open

20%

Both

27%

Other Platform Open

5%

Closed

48%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

020406080100120140160180200220240260Total Publications
20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025

Open

Closed

Publisher Open

49%OA Journal

OA Journal 49%

349

Hybrid 22%

162

No Guarantees 29%

205

Other Platform Open

Institution 61%

296

Domain 61%

295

Other Internet 7%

33

Preprint 3%

16

Public 1%

5

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
299
doaj.org OAI-PMH Repository
Institution
203
Unknown Repository
Other Internet
22
DOI
Other Internet
14
LA Referencia
Institution
9
Royal Netherlands Academy of Arts and Sciences
Institution
8
Le Centre pour la Communication Scientifique Directe - HAL - Diderot
Institution
8
Ghent University
Institution
8
Asklepios Klinik St. Georg
Institution
8
Hospitais da Universidade de Coimbra
Institution
7
1 / 11

Data updated 12 August 2026

Share

Share

Share